BBNXBeta Bionics, Inc.
$19.15-9.8% 1Y
$19.15
$8.8652 weeks$31.99
Is the price fair?
What BBNX's price assumes
Beta Bionics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 5.87× revenue.
5.87
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.72
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 2.72
- EV / EBIToperating margin −70%: the multiple describes the denominator
- not meaningful
- Market capitalisation45.0 million shares, counted Jul 27, 2026
- $862M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry